参考文献/References:
[1] Lim SH, Ardern-Holmes S, Mc Cowage G, et al. Systemic
therapy in neurofibromatosis type 2 [J]. Cancer Treat Rev,
2014, 40(7): 857-861.
[2] 王马军. 神经纤维瘤病-Ⅱ型的诊断和治疗[J]. 浙江创伤
外科，2011，16（1）：31-33.
[3] Radek M, Tomasik B, Wojdyn M, et al. Neurofibromatosis
type 2 (NF 2) or schwannomatosis--Case report study and
diagnostic criteria [J]. Neurol Neurochir Pol, 2016, 50(3):
219-225.
[4] 雷 霆. 小儿神经外科学[M]. 第2版. 北京：人民卫生出
版社，2011. 215-216.
[5] Peyre M, Goutagny S, Bah A, et al. Conservative manage-
ment of bilateral vestibular schwannomas in neurofibroma-
tosis type 2 patients: hearing and tumor growth results [J].
Neurosurgery, 2013, 72(6): 907- 914.
[6] Picry A, Bonne NX, Ding J, et al. Long-term growth rate of
vestibular schwannoma in neurofibromatosis 2: a volume-
tric consideration [J]. Laryngoscope, 2016, 126(10): 2358-
2362.
[7] Blakeley JO, Evans DG, Adler J, et al. Consensus recom-
mendations for current treatments and accelerating clinical
trials for patients with neurofibromatosis type 2 [J]. Am J
Med Genet A, 2012, 158A(1): 24-41.
[8] Kim BS, Seol HJ, Lee JI, et al. Clinical outcome of neurofi-
bromatosis type 2-related vestibular schwannoma: treatment
strategies and challenges [J]. Neurosurg Rev, 2016, 39(4):
643-653.
[9] Karajannis MA, Legault G, Hagiwara M, et al. PhaseⅡtrial
of lapatinib in adult and pediatric patients with neurofibro-
matosis type 2 and progressive vestibular schwannomas [J].
Neuro Oncol, 2012, 14(9): 1163-1170.
[10] Plotkin SR, Merker VL, Halpin C, et al. Bevacizumab for
progressive vestibular schwannoma in neurofibromatosis
type 2: a retrospective review of 31 patients [J]. Otol Neuro-
tol, 2012, 33(6): 1046-1052.
[11] Blakeley JO, Ye X, Duda DG, et al. Efficacy and biomarker
study of bevacizumab for hearing loss resulting from neuro-
fibromatosis type 2-associated vestibular schwannomas [J].
J Clin Oncol, 2016, 34(14): 1669-1675.
[12] Karajannis MA, Legault G, Hagiwara M, et al. Phase Ⅱ
study of everolimus in children and adults with neurofibro-
matosis type 2 and progressive vestibular schwannomas [J].
Neuro Oncol, 2014, 16(2): 292-7.
[13] Goutagny S, Raymond E, Esposito-Farese M, et al. PhaseⅡ
study of mTORC1 inhibition by everolimus in neurofibro-
matosis type 2 patients with growing vestibular schwanno-
mas [J]. J Neurooncol, 2015, 122(2): 313-320.
[14] Zhang L, Li D, Wan H, et al. Hypoglossal-facial nerve
'side'-to-side neurorrhaphy using a predegenerated nerve
autograft for facial palsy after removal of acoustic tumours
at the cerebellopontine angle [J]. J Neurol Neurosurg
Psychiatry, 2015, 86(8): 865-872.
[15] 蒋 雯，张 华. 听觉脑干植入效果及新进展[J]. 听力学
及言语疾病杂志，2015，23（4）：435-437.
[16] Matthies C, Brill S, Kaga K, et al. Auditory brainstem imp-
lantation improves speech recognition in neurofibromatosis
typeⅡpatients [J]. ORL J Otorhinolaryngol Relat Spec,
2013, 75(5): 282-295.
相似文献/References:
[1]陈大瑜 姚国杰 张 戈 李成才 杜 威 韦 可 甘志强 龚 杰.大中型听神经瘤的显微手术治疗及面神经的保护[J].中国临床神经外科杂志,2015,(12):724.[doi:10.13798/j.issn.1009-153X.2015.12.006]
CHEN Da-yu,YAO Guo-jie,ZHANG Ge,et al.Microsurgical treatment of large and middle acoustic neuromas and intraoperative preservation of facial nerves[J].,2015,(07):724.[doi:10.13798/j.issn.1009-153X.2015.12.006]
[2]王玉峰 郭 庚 万大海 郝解贺.磨除内听道在听神经瘤手术中的意义[J].中国临床神经外科杂志,2015,(08):456.[doi:10.13798/j.issn.1009-153X.2015.08.003]
WANG Yu-feng,GUO Geng,WAN Da-hai,et al.Value of rubbing off the posterior wall of internal auditory meatus to surgery for acoustic neuromas[J].,2015,(07):456.[doi:10.13798/j.issn.1009-153X.2015.08.003]
[3]李 扬 何强华 杨 华.枕下乙状窦后锁孔入路手术切除听神经瘤[J].中国临床神经外科杂志,2016,(10):603.[doi:10.13798/j.issn.1009-153X.2016.10.011]
LI Yang,HE Qiang-hua,YANG Hua..Microsurgery via suboccipital retrosigmoid keyhole approach for acoustic neuromas[J].,2016,(07):603.[doi:10.13798/j.issn.1009-153X.2016.10.011]
[4]兰 静 江普查 曹长军 陈礼道 赵宇航 杨 强.枕下乙状窦后入路显微手术切除听神经瘤的临床分析[J].中国临床神经外科杂志,2017,(09):665.[doi:10.13792017.09/j.issn.1009-153X.2017.09.021]
[5]常书锋 杨 波 郑 鲁 黄晓峰 付战胜 杨万敬 刘 昌 王俊善.枕下乙状窦后入路锁孔手术治疗大型听神经瘤31例[J].中国临床神经外科杂志,2018,(07):494.[doi:10.13798/j.issn.1009-153X.2018.07.016]
[6]孙守家 赵 凯 王俊文 朱明欣 蒋 伟 杨正明 舒 凯 雷 霆.枕下乙状窦后入路锁孔手术切除听神经瘤[J].中国临床神经外科杂志,2019,(02):65.[doi:10.13798/j.issn.1009-153X.2019.02.001]
SUN Shou-jia,ZHAO Kai,WANG Jun-wen,et al.Retrospective analysis of resecting acoustic neuromas by keyhole surgery via suboccipital retrosigmoid approach[J].,2019,(07):65.[doi:10.13798/j.issn.1009-153X.2019.02.001]
[7]谷速杰 李 俊 李闪闪 王 潞 范明波 张 章.听神经瘤切除术中内听道内肿瘤的个体化处理[J].中国临床神经外科杂志,2019,(02):69.[doi:10.13798/j.issn.1009-153X.2019.02.002]
GU Su-jie,LI Jun,LI Shan-shan,et al.Individualized treatment of tumors in the internal auditory canals during resection of acoustic neuromas[J].,2019,(07):69.[doi:10.13798/j.issn.1009-153X.2019.02.002]
[8]翁秀珍.耳后锁孔入路手术切除听神经瘤围手术期的护理[J].中国临床神经外科杂志,2022,27(02):119.[doi:10.13798/j.issn.1009-153X.2022.02.017]
[9]陆万流 李廷阳 叶 静 农胜德 韦 维 李忠华.大中型听神经瘤术后面神经功能的影响因素[J].中国临床神经外科杂志,2022,27(03):198.[doi:10.13798/j.issn.1009-153X.2022.03.015]
[10]屈晓东,张晟豪,曹丽,等.神经纤维瘤病合并多发脑膜瘤及三叉神经鞘瘤1例[J].中国临床神经外科杂志,2022,27(05):348.[doi:10.13798/j.issn.1009-153X.2022.05.004]